EUCR   $10.04  0.0 Market Closed

Eucrates Biomedical Acquisition Corp
Total Cash 18.86K
totalCashPerShare 0.004
EBITDA
Total Debt 60.06K
quickRatio 0.29
currentRatio 2.029
Total Revenue
debtToEquity
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -630.29K
earningsGrowth 0.23
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 42.27M
forwardPE
floatShares 1.59M
sharesOutstanding 4.21M
sharesShort 1.16K
sharesShortPriorMonth 1.16K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.62%
heldPercentInstitutions 0.09%
Short Ratio help_outline 1.04%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.884
Price To Book help_outline
earningsQuarterlyGrowth -0.43
netIncomeToCommon 2.42M
trailingEps 0.21%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 9
lastUpdated June 26, 2023, 2:30 p.m.